- |||||||||| Reimbursement, Journal: PERSPECTIVES: Insurance markets, labor markets, and the mental health services delivery system. (Pubmed Central) - Jun 8, 2020
This work demonstrated, using a price adjustment process, that there is no viable price that would make aripiprazole cost-effective for incorporation in the Brazilian public health system in the first-line of treatment of schizophrenia. The drug can be useful in specific cases, since individual variability of response to antipsychotic drugs is important.
- |||||||||| ziprasidone / Generic mfg.
Clinical, PK/PD data, Journal: Physiologically-based pharmacokinetics of ziprasidone in pregnant women. (Pubmed Central) - May 15, 2020 The drug can be useful in specific cases, since individual variability of response to antipsychotic drugs is important. The PBPK model predicted the impact of physiological changes during pregnancy on PK and exposure of ziprasidone, suggesting that dose adjustment is not necessary in this special population.
- |||||||||| Clinical, PK/PD data, Review, Journal: Clinical Pharmacokinetics of Atypical Antipsychotics: An Update. (Pubmed Central) - Nov 2, 2019
This review concentrates on the clinical pharmacokinetic data related to clozapine, risperidone, paliperidone, olanzapine, quetiapine, amisulpride, ziprasidone, aripiprazole, sertindole, asenapine, iloperidone, lurasidone, brexpiprazole and cariprazine and briefly considers the main aspects of their pharmacodynamics. Optimal plasma concentration ranges are proposed for clozapine, risperidone, paliperidone and olanzapine because the studies of quetiapine, amisulpride, asenapine, iloperidone and lurasidone provide only limited information and there is no direct evidence concerning ziprasidone, aripiprazole, sertindole, brexpiprazole and cariprazine: the few reported investigations need to be confirmed and extended.
- |||||||||| Latuda (lurasidone oral) / Sumitomo Dainippon, Geodon (ziprasidone) / RaQualia, Meiji Seika, Pfizer
Retrospective data, Review, Journal: Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis. (Pubmed Central) - Apr 28, 2019 Thus, the newly developed DGP-AG-MMT composites are appropriate for gastroretentive ZIP delivery over an extended period of time. In this network meta-analysis, lurasidone was found to be more efficacious than aripiprazole and ziprasidone, and was associated with less weight gain than quetiapine and olanzapine and less somnolence than quetiapine and ziprasidone.
|